Regeneron Pharmaceuticals
REGN
REGN
1,090 hedge funds and large institutions have $64.1B invested in Regeneron Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 381 increasing their positions, 403 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.3% more ownership
Funds ownership: 85.27% → 86.57% (+1.3%)
5% less repeat investments, than reductions
Existing positions increased: 381 | Existing positions reduced: 403
38% less call options, than puts
Call options by funds: $698M | Put options by funds: $1.12B
Holders
1,090
Holding in Top 10
22
Calls
$698M
Puts
$1.12B
Top Buyers
| 1 | +$1.37B | |
| 2 | +$990M | |
| 3 | +$437M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$261M |
| 5 |
State Street
Boston,
Massachusetts
|
+$227M |
Top Sellers
| 1 | -$339M | |
| 2 | -$230M | |
| 3 | -$173M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$171M |
| 5 |
Harris Associates
Chicago,
Illinois
|
-$159M |